Associate Director, Medical Writing

Associate Director, Medical Writing Remote / QED Medical Writing / Full-time With a singular focus, QED is devoted to the development of our investigational candidate, infigratinib. A first-in-class, selective, tyrosine kinase inhibitor, infigratinib has promising early clinical data in patients with previously treated, FGFR-driven cholangiocarcinoma and metastatic urothelial carcinoma, as well as preclinical studies in […]

The post Associate Director, Medical Writing appeared first on Remote.co.

Read More
Remote.co

Scroll to Top